Browsing by Author "Ciruelos, Eva"

Sort by: Order: Results:

  • Colomer, Ramon; Aranda-Lopez, Ignacio; Albanell Mestres, Joan; García-Caballero, Tomás; Ciruelos, Eva; Lopez-García, M. A.; Cortés, Javier; Rojo, Federico; Martín, M.; Palacios-Calvo, J. (SpringerOpen, 2018)
    This consensus statement revises and updates the recommendations for biomarkers use in the diagnosis and treatment of breast cancer, and is a joint initiative of the Spanish Society of Medical Oncology and the Spanish ...
  • Sánchez-Rovira, Pedro; Zamora, Pilar; Salvador-Bofill, Javier; Morales, Serafín; Martínez-Jáñez, Noelia; Martínez-de-Dueñas, Eduardo; Lluch, Ana; Illarramendi, José Juan; Gómez-Pardo, Patricia; Gavilá Gregori, Joaquín; García-Palomo, Andrés; García-Mata, Jesús; Fernández, Yolanda; del Barco, Sonia; de Juan, Ana; Ciruelos, Eva; Chacón, José Ignacio; Calvo, Lourdes; Barnadas, Agustí; Albanell Mestres, Joan (Taylor & Francis, 2019)
    Objective: The aim of this survey conducted by 20 leading Spanish oncologists was to analyze the concurrence between Spanish clinical practice and the recently published definition of the optimal sequence for the systemic ...
  • Ciruelos, Eva; Alba, Emilio; López, Rafael; Lluch, Ana; Martín, Miguel; Arroyo, Isabel; Navarro, Beatriz; Carcedo, David; Colomer, Ramon; Albanell Mestres, Joan (Impact Journals, 2019)
    Introduction: Trastuzumab has become the standard treatment for both HER2-positive early and metastatic breast cancer (HER2+ eBC or mBC) since its approval. The objective of the study is to estimate the benefit of adjuvant ...
  • Gámez Pozo, Angelo; Trilla Fuertes, Lucía; Prado Vázquez, Guillermo; Chiva, Cristina; López Vacas, Rocío; Nanni, Paolo; Berges Soria, Julia; Grossmann, Jonas; Díaz Almirón, Mariana; Ciruelos, Eva; Sabidó Aguadé, Eduard, 1981-; Espinosa Arranz, Enrique; Fresno Vara, Juan Ángel (Public Library of Science (PLoS), 2017)
    BACKGROUND: Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancers and usually requires the administration of adjuvant chemotherapy after surgery but even with this treatment many patients still ...
  • Rojas Laimito, Katerin; Trilla Fuertes, Lucía; Gámez Pozo, Angelo; Chiva, Cristina; Sepúlveda, Juan M.; Manso, Luis; Prado Vázquez, Guillermo; Zapater-Moros, Andrea; López Vacas, Rocío; Ferrer-Gómez, María; Mendiola, César; Espinosa Arranz, Enrique; Sabidó Aguadé, Eduard, 1981-; Ciruelos, Eva; Fresno Vara, Juan Ángel (Cancer Intelligence, 2019)
    Background: Breast cancer (BC) is the most frequent tumour in women. Triple negative tumours (TNBC)–which are associated with minor survival rates—lack markers predictive of response to anticancer drugs. Triple negative ...
  • Ayala de la Peña, F.; Andrés, Raquel; Garcia-Saenz, José Angel; Manso, Luis; Margeli, M. E.; Dalmau, M. E.; Pernas, S.; Prat, Aleix; Servitja Tormo, Sonia; Ciruelos, Eva (SpringerOpen, 2019)
    Breast cancer is the most common cancer in women in our country and it is usually diagnosed in the early and potentially curable stages. Nevertheless, around 20-30% of patients will relapse despite appropriate locoregional ...
  • Garcia-Saenz, José Angel; Bermejo, Begoña; Estevez, L. G.; Palomo, A. G.; González-Farré, X.; Margeli, M. E.; Pernas, S.; Servitja Tormo, Sonia; Rodríguez, C. A.; Ciruelos, Eva (Springer, 2015)
    Breast cancer is a major public health problem. Despite remarkable advances in early diagnosis and treatment, one in three women may have metastases since diagnosis. Better understanding of prognostic and predictive factors ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking